الفهرس 
Title : The safety and efficacy of direct oral anticoagulant post bariatric surgeries
ContantsOnly 14 pages are availabe for public view
 |  | from | 143 |  |  |
| | | from | 143 | | |
Abstract
Background; Obesity is a global epidemic and bariatric surgery is used
with increasing frequency to treat its complications. The extent to which
bariatric surgery alters the efficacy, safety, and pharmacokinetics of
direct oral anticoagulants (DOACs) is unknown, Aim and objectives; to
evaluate the safety and efficacy of direct oral anti coagulant post bariatric
surgery, Subjects and methods: This study was single arm clinical trial,
was conducted at General surgery department, Cairo University hospitals
on 40 Patients undergoing bariatric surgery between November 2021 and
April 2022, Result; There was statistically insignificant difference
between types of operation regarding complications, Conclusion;
Obesity is a global epidemic and bariatric surgery is used with increasing
frequency to prevent and treat its complications. There remains
considerable uncertainty on the optimal anticoagulant strategy after
bariatric surgery despite how commonly these patients develop VTE or
atrial fibrillation. Future research should compare DOACs with warfarin
and correlate DOAC pharmacokinetic parameters with adverse clinical
outcomes in this population.